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Introduction: Limited data currently exists regarding the diagnostic indicators of peptic ulcer 
perforation for early detection among patients in Thailand. Delayed diagnosis and treatment for 
an ulcer can be life-threatening, resulting in shock or death.
Objective: To determine the diagnostic indicators of peptic ulcer perforation.
Material and methods: A cohort study was conducted in a tertiary care hospital in Thailand 
from 2005 to 2009. Peptic ulcer patients aged 15 years and over admitted to the surgical depart-
ment were included. The diagnostic indicators used criteria of the patients’ final diagnoses 
and operations, coded according to the International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision, which included patient profiles, gender, age, coexisting 
illnesses, personal habits, signs and symptoms, laboratory investigations, radiological finding, 
and treatment role. Exponential risk regression analyses to obtain relative risk (RR) estimates 
for diagnostic indicators were analyzed using Stata® statistical software package, version 11 
(StataCorp LP, College Station, TX).
Results: The study included 1290 patients. Of these, 57% reported perforated peptic ulcer. 
Multivariate analysis showed five diagnostic indicators: signs and symptoms including intense 
abdominal pain (RR = 1.53, 95% confidence interval [CI] 1.14–2.06), tenderness (RR = 1.94, 
95% CI 1.17–3.21), and guarding (RR = 1.52, 95% CI 1.05–2.20); X-ray with free air (RR = 2.80, 
95% CI 2.08–3.77); and referral from other hospitals (RR = 1.37, 95% CI 1.03–1.82).
Conclusion: Five diagnostic indicators for peptic ulcer perforation monitoring were suggested 
from this study. Improving diagnostic indicators for medical care may improve the outcome of 
patients that have perforated peptic ulcer.
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Introduction
Peptic ulcer perforation (PUP) is the most common severe complication for a 
  peptic ulcer.1–3 Many studies have assessed the risk factors associated with PUP.4–8 The 
incidence of PUP in Thailand was 10% of peptic ulcers.9 PUP accounts for 5% of all 
abdominal emergencies.1–3,10 PUP is a major cause of death worldwide and continues 
to be a serious health problem in many hospitals in Thailand. In Nakornping Hospital 
(Chiang Mai), the PUP rate increased from 14.1% in 1994 to 21.9% of all peptic ulcer 
patients in the surgical department in 2004.11 It is one of the top five conditions for 
hospital admissions.1–3,10,11
In clinical practice, patients with PUP usually present with a sudden onset of severe 
abdominal pain and gastrointestinal bleeding.2,10 Patients with PUP range from indi-
viduals who are completely asymptomatic to those who develop severe   complications. Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Comprehensive understanding of the signs, symptoms, 
and pathogenesis of PUP requires an experienced medical 
management team with knowledge of indicators associated 
with PUP.
Currently, there is no gold standard for diagnosis of PUP 
and there is limited data regarding diagnostic indicators for 
early detection of PUP among patients in Thailand. The aim 
of this study was to determine specific diagnostic indicators 
of PUP based on patients’ personal habits, physical examina-
tion, signs and symptoms, laboratory investigations, radio-
logical finding, and treatment role, which would be useful 
for doctors and nurses in emergency or surgical departments. 
These indicators would establish prompt diagnosis in order 
to reduce PUP and risk of death from delayed treatment.5,7,12 
Diagnostic indicators of PUP are needed for early detection 
among patients undergoing perforation in order to improve 
clinical outcome.
Material and methods
inclusion criteria and diagnosis
Patients aged 15 years or older who were admitted to the 
surgical department of Nakornping Hospital for severe 
abdominal pain, gastrointestinal bleeding, or hemorrhage 
due to gastric or duodenal ulcer perforation, and with signs 
and symptoms of serious bleeding or intense abdominal pain, 
were included in the study. Invariably, the definitive diagnosis 
for PUP was obtained postoperation for the patients’ final 
diagnosis of gastric or duodenal ulcer.
Exclusion criteria
Patients with misplaced or incomplete records and patients 
diagnosed with perforation from malignant ulcers were 
excluded.
The medical records of all patients undergoing surgery 
for PUP from January 1, 2006 to December 31, 2009 at a ter-
tiary care hospital in Thailand were reviewed retrospectively. 
The project was approved by the Ethical Review Committee 
for Research in Human Subjects, Chiang Mai University’s 
Faculty of Medicine and Ethics Committee, and the Ethical 
Committee and/or the director of Nakornping Hospital.
Subsequently, data collection including emergency 
records, nurse notes, diagnostic reports, routine laboratory 
and radiological findings, progress notes, and operative 
notes were reviewed by the research nurse and attending 
  physicians. These were obtained from patients’ medical 
records, nurse notes, and anesthetic records. Data included 
patient demographics (gender and age), coexisting   illnesses 
(diabetes mellitus, hypertension, chronic obstructive 
pulmonary disease, asthma, liver cirrhosis, heart disease, 
renal disease, and arthritis), personal habits (smoking, alcohol 
consumption, nonsteroidal antiinflammatory drug usage, and 
history of peptic ulcer), signs and symptoms (hematemesis, 
intense abdominal pain, tenderness, guarding, melena, 
systolic blood pressure, and pain onset time), laboratory 
investigations (hemoglobin, hematocrit, blood urea nitrogen, 
and creatinin), radiological finding (X-ray with free air), and 
treatment role (referral from other hospitals). This study 
period found that no patients had recurring perforations or 
multiple admissions.
Following review, pertinent data were recorded on pre-
printed data collection forms. Completed data collection forms 
were edited and analyzed at the study data processing center.
Definitions
PUPs included gastric ulcer perforation and duodenal ulcer 
perforation. Final diagnosis was determined postoperation 
according to the International Statistical Classification of 
  Diseases and Related Health Problems, 10th Revision: 
  gastric ulcer (coded K25, subcategories 25.1, 25.2, 25.5, 
25.6) or duodenal ulcer (coded K26, subcategories 26.1, 
26.2, 26.5, 26.6).13
Statistical analysis
Demographic data were presented as percentage, mean, and 
standard deviation. All continuous data were tested for nor-
mal distribution with the Shapiro–Wilk test. Parametric tests 
were used based on normal distributions, and nonparametric 
tests were performed when assumptions were not met.
Contingency tables were constructed to analyze the relation-
ships between PUP patients and peptic ulcer with no perforation 
patients. Comparison of data between the two patient groups 
were undertaken with Pearson’s chi-square test or Fisher’s 
exact test for categorical data and Student’s t-test or Wilcoxon 
rank-sum test for continuous data. All variables, explored by 
univariable analyses, were entered into a multivariable expo-
nential risk regression analysis to evaluate the relative risk (RR) 
of PUP for the diagnostic variables.   Differences were consid-
ered statistically significant when P , 0.05. All analyses were 
performed using Stata® statistical software package, version 11 
(StataCorp LP, College Station, TX).
Results
Patient characteristics
During the study period, 1290 patients were included in the 
study; 285 patients with misplaced or incomplete records 
were excluded. Of included patients, 57% (740 patients) Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 1 Baseline characteristics of peptic ulcer perforation
Characteristics PUP PUNP P value
(n = 740) % (n = 550) %
Gender
    Male 436 58.92 453 82.36 ,0.001
    Female 304 41.08 97 17.64
Age (years)
  ,60 225 30.41 420 76.36 ,0.001
  $60 515 69.59 130 23.64
    Median (iQr) 71 (14–92) 52 (32–85) ,0.001
Coexisting illnesses
    Diabetes mellitus 141 19.05 58 10.55 ,0.001
    hypertension 132 17.84 188 34.08 ,0.001
    COPD 66 8.92 32 5.82 0.038
    Asthma 3 0.41 3 0.55 0.51
    Liver cirrhosis 75 10.14 3 0.55 ,0.001
    heart disease 120 16.22 51 9.27 ,0.001
    renal disease 67 90.5 62 11.27 0.189
    Arthritis 75 10.14 37 6.73 0.032
    history of peptic ulcer 398 53.78 93 16.91 ,0.001
Personal habits
    Smoking 513 69.32 252 45.82 ,0.001
    Alcohol consumption 399 53.92 211 38.36 ,0.001
    nSAiD usage 199 26.89 100 18.18 ,0.001
Signs and symptoms
  hematemesis 200 27.03 229 41.64 ,0.001
  intense abdominal pain 683 92.30 214 38.91 ,0.001
  Tenderness 714 96.49 261 47.45 ,0.001
  Guarding 684 92.43 155 28.18 ,0.001
  Melena 57 7.70 129 23.45 ,0.001
  Systolic blood pressure (mmhg)
  $ 100 303 40.95 502 91.27 ,0.001
  , 100 437 59.05 48 8.73
    Median (iQr) 98 (68–162) 119 (99–215) ,0.001
  Pain onset time (hours)
  , 24 323 43.65 522 94.91 ,0.001
  $ 24 417 56.35 28 5.09
    Median (iQr) 24 (1–68) 6 (1–47) ,0.001
Laboratory finding
    hemoglobin (mg/dL)
    Mean ± SD 10.55 ± 2.26 10.41 ± 2.52 0.853
    hematocrit (%)
  $ 30 344 46.49 235 42.73 0.179
  , 30 396 53.51 315 57.27
    Mean ± SD 30.80 ± 6.81 30.99 ± 7.83 0.354
    BUn (mg/dL)
    Median (iQr) 30.34 (3.60–213.50) 26.50 (1.00–111.80) ,0.001
    Creatinin (mg/dL)
    Median (iQr) 2.48 (0.25–31.5) 1.69 (0.25–61) ,0.001
    BUn/creatinin ratio
  , 12 142 19.19 225 40.91 ,0.001
  $ 12 598 80.81 325 59.09
Radiological finding
    X-ray with free air
    no 70 9.46 494 89.82 ,0.001
    Yes 670 90.54 56 10.18
(Continued)Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 1 (Continued)
Characteristics PUP PUNP P value
(n = 740) % (n = 550) %
Treatment role
    referral from other hospitals
    no 57 7.70 230 41.82 ,0.001
    Yes 683 92.30 320 58.18
Abbreviations: BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; NSAID, nonsteroidal antiinflammatory drug; PUNP, 
peptic ulcer with no perforation; PUP, peptic ulcer perforation.
reported PUP, 58.92% (436 patients) were male, and the 
median age was 71 (interquartile range 14–92) years, with 
69.59% (515 patients) aged $60 years. There were statistical 
differences between PUP patients and peptic ulcer with no 
perforation patients in coexisting illnesses (diabetes mellitus 
P , 0.001, hypertension P , 0.001, chronic obstructive pul-
monary disease P = 0 .038, liver cirrhosis P , 0.001, heart 
disease P , 0.001, arthritis P = 0.032, and history of peptic 
ulcer P , 0.001), personal habits (smoking P , 0.001, alcohol 
consumption P , 0.001, and nonsteroidal antiinflammatory 
drug usage P , 0.001), signs and symptoms (hematemesis 
P , 0.001, intense abdominal pain P , 0.001, tenderness 
P , 0.001, guarding P , 0.001, melena P , 0.001, systolic 
blood pressure ,100 mmHg P , 0.001, and pain onset time 
$ 24 hours P , 0.001), laboratory investigations (blood urea 
nitrogen/creatinin ratio $ twelvefold P , 0.001), radiological 
finding (X-ray with free air P , 0.001), and treatment role 
(referral from other hospitals P , 0.001). In other variables, 
there were no statistical differences (Table 1).
Diagnostic indicators
The results of univariable analyses of diagnostic indicators, 
including patient demographics and clinical variables from 
Table 1, in relation to PUP are presented in Table 2. The fol-
lowing variables were significantly associated with PUP in 
the crude analyses: male patients (RR = 1.55, 95% confidence 
interval [CI] 1.42–1.69); age $60 years (RR = 2.29, 95% CI 
1.96–2.68); coexisting illnesses (diabetes mellitus [RR = 1.29, 
95% CI 1.07–1.55], liver cirrhosis [RR = 1.75, 95% CI 
1.38–2.23], heart disease [RR = 1.27, 95% CI 1.04–1.54], 
and history of peptic ulcer [RR = 1.89, 95% CI 1.64–2.19]); 
personal habits (smoking [RR = 1.55, 95% CI 1.33–1.81], 
alcohol consumption [RR = 1.30, 95% CI 1.13–1.51], and 
nonsteroidal antiinflammatory drug usage [RR = 1.22, 95% 
CI 1.04–1.40]), signs and symptoms (intense abdominal pain 
[RR = 5.25, 95% CI 4.01–6.88], tenderness [RR = 8.87, 95% 
CI 6.00–13.12], guarding [RR = 6.57, 95% CI 5.00–8.62], 
systolic blood pressure ,100 mmHg [RR = 2.39, 95% CI 
1.01–2.77], and pain onset time $24 hours [RR = 2.45,   
95% CI 2.12–2.83]); laboratory investigations (blood urea 
nitrogen/creatinin ratio $ twelvefold [RR = 1.67, 95% 
CI 1.39–2.01]); radiological finding (X-ray with free air 
[RR = 7.44, 95% CI 5.81–9.51]); and treatment role (referral 
from other hospitals [RR = 3.43, 95% CI 2.62–4.49]).
The multivariable analysis found five diagnostic indica-
tors that were significantly related to PUP: signs and symp-
toms including intense abdominal pain (RR = 1.53, 95% CI 
1.14–2.06), tenderness (RR = 1.94, 95% CI 1.17–3.21), and 
guarding (RR = 1.52, 95% CI 1.05–2.20); radiological find-
ing of plain abdominal X-ray with free air (RR = 2.80, 95% 
CI 2.08–3.77); and referral from other hospitals (RR = 1.37, 
95% CI 1.03–1.82) (Table 2).
Discussion
Five diagnostic indicators, including three signs and symp-
toms of PUP (intense abdominal pain, tenderness, and 
guarding) were significantly different from peptic ulcer 
patients with no perforation. In the literature,2 it is suggested 
that gastrointestinal perforation often leads to catastrophic 
  consequences. Erosion of the gastrointestinal wall by the 
ulcer leads to spillage of stomach or intestinal content into 
the abdominal cavity. Perforation at the anterior surface of the 
stomach leads to the first sign which is often sudden intense 
abdominal pain. Posterior wall perforation leads to tenderness 
and guarding, which often radiates pain to the back.
A plain abdominal X-ray, which showed free air, was used 
in the diagnosis of PUP in the hospital setting during the study 
period. A previous study used fast ultrasound or computerized 
tomography scan to confirm diagnosis and early treatment of 
PUP as plain abdominal X-ray does not always prove perfo-
ration, particularly in the early stages.14,15 Several case series 
have shown that in 30%–50% of patients, the X-ray may be 
negative for free air, particularly in the elderly.15 Unfortunately, 
ultrasound and computed tomography scans are limited in a 
developing country such as Thailand. Therefore, most cases in 
this study could not be confirmed by using this equipment.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table  2  Univariable  and  multivariable  analysis  risk  ratio  and  95%  confidence  interval  of  diagnostic  indicators  for  peptic  ulcer 
perforation
Diagnostic indicators Crude RR 95% CI P value Multivariable RR 95% CI P value
Gender
    Female 1.00 reference reference
    Male 1.55 (1.42–1.69) ,0.001 1.09 (0.94–1.27) 0.263
Age (years)
    ,60 1.00 reference reference
    $60 2.29 (1.96–2.68) ,0.001 1.19 (0.90–1.58) 0.22
Coexisting illnesses
    Diabetes mellitus
      no 1.00 reference reference
      Yes 1.29 (1.07–1.55) 0.006 0.97 (0.80–1.18) 0.782
    hypertension
      no 1.00 reference reference
      Yes 0.66 (0.55–0.79) ,0.001 0.93 (0.76–1.15) 0.525
    COPD
      no 1.00 reference reference
      Yes 1.19 (0.93–1.53) 0.175 0.96 (0.72–1.27) 0.771
    Asthma
      no 1.00 reference reference
      Yes 0.87 (0.28–2.71) 0.811 1.08 (0.32–3.61) 0.902
    Liver cirrhosis
      no 1.00 reference reference
      Yes 1.75 (1.38–2.23) ,0.001 1.05 (0.82–1.34) 0.719
    heart disease
      no 1.00 reference reference
      Yes 1.27 (1.04–1.54) 0.018 1.05 (0.85–1.30) 0.672
    renal disease
      no 1.00 reference reference
      Yes 0.90 (0.70–1.15) 0.391 0.89 (0.69–1.17) 0.408
    Arthritis
      no 1.00 reference reference
      Yes 1.19 (0.93–1.51) 0.161 1.25 (0.97–1.61) 0.090
Personal habits
    Smoking
      no 1.00 reference reference
      Yes 1.55 (1.33–1.81) ,0.001 1.07 (0.87–1.31) 0.509
    Alcohol consumption
      no 1.00 reference reference
      Yes 1.30 (1.13–1.51) ,0.001 1.05 (0.86–1.29) 0.605
    nSAiD usage
      no 1.00 reference reference
      Yes 1.22 (1.04–1.40) 0.017 1.09 (0.92–1.29) 0.333
    history of peptic ulcer
      no 1.00 reference reference
      Yes 1.89 (1.64–2.19) ,0.001 1.13 (0.97–1.32) 0.128
Signs and symptoms
    hematemesis
      no 1.00 reference reference
      Yes 0.74 (0.63–0.87) ,0.001 0.97 (0.81–1.16) 0.716
    intense abdominal pain
      no 1.00 reference reference
      Yes 5.25 (4.01–6.88) ,0.001 1.53 (1.14–2.06) 0.005
    Tenderness
      no 1.00 reference reference
      Yes 8.87 (6.00–13.12) ,0.001 1.94 (1.17–3.21) 0.010
(Continued)Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 2 (Contiuned)
Diagnostic indicators Crude RR 95% CI P value Multivariable RR 95% CI P value
    Guarding
      no 1.00 reference reference
      Yes 6.57 (5.00–8.62) ,0.001 1.52 (1.05–2.20) 0.026
    Melena
      no 1.00 reference reference
      Yes 0.50 (0.38–0.65) ,0.001 0.86 (0.63–1.16) 0.330
    Systolic blood pressure (mmhg)
    $100 1.00 reference reference
    ,100 2.39 (1.01–2.77) ,0.001 1.11 (0.83–1.46) 0.484
    Pain onset time (hours)
     , 24 1.00 reference reference
     $ 24 2.45 (2.12–2.83) ,0.001 1.22 (0.99–1.50) 0.058
Laboratory findings
    hemoglobin (g/dL)
     $ 10 1.00 reference 1.00 reference
     , 10 1.01 (0.98–1.04) 0.488 1.01 (0.94–1.09) 0.720
    hematocrit (%)
     $ 30 1.00 reference 1.00 reference
     , 30 1.07 (0.92–1.23) 0.381 1.00 (0.97–1.02) 0.855
    BUn/creatinin ratio
     , 12 1.00 reference reference
     $ 12 1.67 (1.39–2.01) ,0.001 1.08 (0.88–1.32) 0.470
Radiological finding
    X-ray with free air
      no 1.00 reference reference
      Yes 7.44 (5.81–9.51) ,0.001 2.80 (2.08–3.77) ,0.001
Treatment roles
    referral from other hospitals
      no 1.00 reference reference
      Yes 3.43 (2.62–4.49) ,0.001 1.37 (1.03–1.82) 0.032
Abbreviations: BUN, blood urea nitrogen; CI, confidence interval; COPD, chronic obstructive pulmonary disease; NSAID, nonsteroidal antiinflammatory drug; RR, relative risk.
In the present study, patients who were referred from 
other hospitals were significantly associated with PUP. No 
previous studies have showed this data. Health services in 
Thailand are mainly provided by public hospitals run by 
the Ministry of Public Health, university hospitals, and the 
private sector. Public health services include small health 
centers covering 3000–5500 people, 10–60 bed community 
hospitals covering 20,000–40,000 people, and 100–400 bed 
provincial hospitals covering more than 200,000 people.16 
A patient can visit any of these health services and then 
be referred to a larger hospital if the condition is serious. 
A number of studies concerning referral delays and secondary 
care delays in health care system have been previously 
reported.17,18 Data from the present study suggest that other 
hospital services play a very important role in determining 
the duration of system delay.
In summary, patient referral delays and lack of early 
detection of PUP in Thailand are important weaknesses with 
poor clinical outcomes. Severe PUP requires improved care 
management, avoidance of unnecessary medical treatment, 
and proper referral of patients. The referral system in Thailand 
may need revising. In addition, the findings of this study are 
useful for doctors and nurses in clinical practice in developing 
countries for early detection and treatment of PUP.
Study strengths and weaknesses
A strength of this study is its cohort design. The study was 
able to include all patients admitted to the surgical depart-
ment with an accurate evaluation of patient characteristics 
and careful evaluation of patient records. Several diagnostic 
factors indicate this study to be valid: (1) large sample size 
of patients with PUP, (2) patient characteristics were based 
on real data from clinical practice, and (3) audit process was 
carefully planned and carried out with anonymous medical 
records; detailed medical records were reviewed by both 
surgical gastroenterologists and researchers.
A limitation of this study was the use of retrospec-
tive medical records that were sometimes incomplete. Clinical and Experimental Gastroenterology
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  Unfortunately, it was not always possible to collect all risk 
factors, possibly because those filling out the documents had 
not accounted for a prospective study.
Conclusion
High-risk patients, ie, those who are referred from other 
hospitals with three signs and symptoms of PUP (intense 
abdominal pain, tenderness, and guarding) and present 
plain abdominal X-ray with free air, should be concerned. 
Reducing diagnostic delays in the referral system, with the 
intention of increasing the proportion of early detection of 
PUP, may improve patient outcomes in Thailand.
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